STARMED America
Tracked across 1 events · 6 articles · First seen Jun 30, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: STARMED America received FDA 510(k) clearance for its thyroid nodule ablation system, making it the first and only company globally with such a specific indication. This significantly enhances its market position and potential for growth in the United States and other countries.
Jun 30, 2026 · 6 articles
ERGEN INTELLIGENCE
Track STARMED America live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard